SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-040719
Filing Date
2021-03-24
Accepted
2021-03-24 08:00:39
Documents
43
Period of Report
2021-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2110673d1_6k.htm 6-K 11904
2 EXHIBIT 99.1 tm2110673d1_ex99-1.htm EX-99.1 74708
3 GRAPHIC tm2110673d1_ex99-1img01.jpg GRAPHIC 853375
4 GRAPHIC tm2110673d1_ex99-1img02.jpg GRAPHIC 584239
5 GRAPHIC tm2110673d1_ex99-1img03.jpg GRAPHIC 282256
6 GRAPHIC tm2110673d1_ex99-1img04.jpg GRAPHIC 959833
7 GRAPHIC tm2110673d1_ex99-1img05.jpg GRAPHIC 502962
8 GRAPHIC tm2110673d1_ex99-1img06.jpg GRAPHIC 190003
9 GRAPHIC tm2110673d1_ex99-1img07.jpg GRAPHIC 405864
10 GRAPHIC tm2110673d1_ex99-1img08.jpg GRAPHIC 475208
11 GRAPHIC tm2110673d1_ex99-1img09.jpg GRAPHIC 350884
12 GRAPHIC tm2110673d1_ex99-1img10.jpg GRAPHIC 390225
13 GRAPHIC tm2110673d1_ex99-1img11.jpg GRAPHIC 301332
14 GRAPHIC tm2110673d1_ex99-1img12.jpg GRAPHIC 262466
15 GRAPHIC tm2110673d1_ex99-1img13.jpg GRAPHIC 299826
16 GRAPHIC tm2110673d1_ex99-1img14.jpg GRAPHIC 194307
17 GRAPHIC tm2110673d1_ex99-1img15.jpg GRAPHIC 301863
18 GRAPHIC tm2110673d1_ex99-1img16.jpg GRAPHIC 367337
19 GRAPHIC tm2110673d1_ex99-1img17.jpg GRAPHIC 291147
20 GRAPHIC tm2110673d1_ex99-1img18.jpg GRAPHIC 349661
21 GRAPHIC tm2110673d1_ex99-1img19.jpg GRAPHIC 330111
22 GRAPHIC tm2110673d1_ex99-1img20.jpg GRAPHIC 402305
23 GRAPHIC tm2110673d1_ex99-1img21.jpg GRAPHIC 213484
24 GRAPHIC tm2110673d1_ex99-1img22.jpg GRAPHIC 325074
25 GRAPHIC tm2110673d1_ex99-1img23.jpg GRAPHIC 328485
26 GRAPHIC tm2110673d1_ex99-1img24.jpg GRAPHIC 353933
27 GRAPHIC tm2110673d1_ex99-1img25.jpg GRAPHIC 415177
28 GRAPHIC tm2110673d1_ex99-1img26.jpg GRAPHIC 263438
29 GRAPHIC tm2110673d1_ex99-1img27.jpg GRAPHIC 272704
30 GRAPHIC tm2110673d1_ex99-1img28.jpg GRAPHIC 372950
31 GRAPHIC tm2110673d1_ex99-1img29.jpg GRAPHIC 369840
32 GRAPHIC tm2110673d1_ex99-1img30.jpg GRAPHIC 374032
33 GRAPHIC tm2110673d1_ex99-1img31.jpg GRAPHIC 325595
34 GRAPHIC tm2110673d1_ex99-1img32.jpg GRAPHIC 376223
35 GRAPHIC tm2110673d1_ex99-1img33.jpg GRAPHIC 384499
36 GRAPHIC tm2110673d1_ex99-1img34.jpg GRAPHIC 131950
37 GRAPHIC tm2110673d1_ex99-1img35.jpg GRAPHIC 960134
38 GRAPHIC tm2110673d1_ex99-1img36.jpg GRAPHIC 543976
39 GRAPHIC tm2110673d1_ex99-1img37.jpg GRAPHIC 326399
40 GRAPHIC tm2110673d1_ex99-1img38.jpg GRAPHIC 402596
41 GRAPHIC tm2110673d1_ex99-1img39.jpg GRAPHIC 251308
42 GRAPHIC tm2110673d1_ex99-1img40.jpg GRAPHIC 335534
43 GRAPHIC tm2110673d1_ex99-1img41.jpg GRAPHIC 361238
  Complete submission text file 0001104659-21-040719.txt   21702016
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 21766707
SIC: 2834 Pharmaceutical Preparations